Schedule 3 (Pharmacist Only Medicine): These medicines require professional advice for safe usage and are available directly from a pharmacist without a prescription
Research has identified these alarming vision-related risks associated with GLP-1 medications: Sudden irreversible vision loss: NAION strikes without warning, often discovered upon waking, causing blurry or dim vision that progresses to immediate and permanent partial or complete blindness in the affected eye with no possibility of restoration Elevated risk across multiple studies: Beyond the Harvard findings showing 4-7 fold increased risk, a University of Southern Denmark study examining over 424,000 patients found weekly semaglutide users faced 2.19 times higher NAION risk European regulatory recognition: In June 2025, the European Medicines Agency officially recognized NAION as a possible side effect of semaglutide medications, marking formal acknowledgment by international regulators Complete absence of treatment options: Medical science currently offers no cure, no effective treatment, and no way to reverse NAION-related vision damage, leaving patients with permanent disability The permanent and irreversible nature of NAION-related optic nerve damage distinguishes these injuries from other complications that may resolve after discontinuing medication
Instead, it affects how your brain perceives hunger, causing you to feel full even after consuming smaller servings
Flat $49 per care visit with no subscription or membership
This distinction matters because 503A pharmacies face different regulatory requirements than 503B outsourcing facilities
J Clin Endocrinol Metab 98:34023410 Sze L, Bernays RL, Zwimpfer C, Wiesli P, Brndle M, Schmid C (2012) Excessively high soluble klotho in patients with acromegaly
